Thomas Lüscher, ESC 2020 – Gut Microbiota and Cardiovascular Disease
We caught up with Prof Thomas Lüscher (Royal Brompton and Harefield Hospital and Imperial College, London, UK) on the association between gut microbiota, the gut microbiome and cardiovascular disease.
- What is known about the association between gut microbiome changes and cardiovascular disease? (0.38)
- Which gut microbiota–dependent metabolites are involved in the pathogenesis of cardiovascular disease? (2.49)
- What novel therapeutic strategies are being investigated for targeting the gut microbiome to improve cardiovascular outcomes? (5.44)
- Could you give us an overview about the most important recent studies? (9.44)
- What are the major gaps in our knowledge and what future studies are planned? (12.13)
Speaker disclosures: Professor Thomas Lüscher has nothing to declare in relation to this video interview.
Support: Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Professor Thomas Lüscher, September 2020.
Share this Video
Related Videos In Cardiovascular Disease
John Forrest, ACC 2023: Evolut low risk trial, transcatheter versus surgical aortic valve replacement in patients at low surgical risk
The Evolut low risk trial aimed to compare transcatheter versus surgical aortic valve replacement in patients who were at low risk for surgery. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to discuss the eligibility criteria, the key findings and the outlook for […]
John Forrest, ACC 2023: The treatment paradigm for patients with aortic stenosis
The treatment paradigm for aortic stenosis has developed dramatically in the past decade. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to outline and discuss the developments. Dr Forrest presented an abstract entitled ‘Transcatheter Versus Surgical Aortic Valve Replacement In Aortic Stenosis Patients […]
Steven Nissen, ACC 2023: Lipid-lowering therapies – current and future options
Many lipid-lowering therapies exist, such as statins to manage and reduce lipid levels. While statins are the most commonly used medication, some patients may need additional interventions to lower their LDL cholesterol levels. In this touchCARDIO interview, we speak with Prof. Steven Nissen (Cleveland Clinic, Cleveland, OH, USA) to explore current and developing novel lipid-lowering […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!